TIMOTHY CULLINANE: Open Payments
NPI 1255376232 · ELMHURST, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,393 in 140 payments from 17 companies in 2025. Trend: 2023 $3,519 · 2024 $3,824 · 2025 $3,393
Food & beverage: $3,305Education: $88
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $497 |
| ABBVIE INC. | 28 | $448 |
| Neurocrine BioSciences, Inc. | 11 | $414 |
| Janssen Pharmaceuticals, Inc | 10 | $361 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $351 |
| Teva Pharmaceuticals USA, Inc. | 16 | $311 |
| Vanda Pharmaceuticals Inc. | 11 | $215 |
| Almatica Pharma LLC | 6 | $156 |
| Alkermes, Inc. | 6 | $151 |
| E.R. Squibb & Sons, L.L.C. | 4 | $117 |
Products named: VRAYLAR, REXULTI, INGREZZA, CAPLYTA, INVEGA SUSTENNA, FANAPT, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across IL — which companies pay providers there.
